Download
s12986-018-0269-8.pdf 1,22MB
WeightNameValue
1000 Titel
  • Cold-pressed minke whale oil reduces circulating LDL/VLDL-cholesterol, lipid oxidation and atherogenesis in apolipoprotein E-deficient mice fed a Western-type diet for 13 weeks
1000 Autor/in
  1. Walquist, Mari Johannessen |
  2. Stormo, Svein Kristian |
  3. Østerud, Bjarne |
  4. Elvevoll, Edel O. |
  5. Eilertsen, Karl-Erik |
1000 Erscheinungsjahr 2018
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2018-05-04
1000 Erschienen in
1000 Quellenangabe
  • 15:35
1000 Copyrightjahr
  • 2018
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12986-018-0269-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935995/ |
1000 Ergänzendes Material
  • https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/s12986-018-0269-8#Sec17 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Long-chain n3-polyunsaturated fatty acids (LC n3-PUFA) are well known for their anti-inflammatory activity and their impact on cardiovascular disease. Cold-pressed whale oil (CWO) has half the amount of LC n3-PUFA compared to cod liver oil (CLO). Still, there has been observed more pronounced beneficial effects on cardiovascular disease markers from intake of CWO compared to intake of CLO in human intervention studies. Extracts from CWO deprived of fatty acids have also been shown to display antioxidative and anti-inflammatory effects in vitro. The aim of this study was to investigate whether intake of a high-fat Western-type diet (WD) supplemented with CWO would prevent the development of atherosclerotic lesions in apolipoprotein E-deficient (ApoE−/−) mice. METHODS: Seventy female ApoE−/− mice were fed a WD containing 1% CWO, CLO or corn oil (CO). Atherosclerotic lesion formation, body and tissue weights, hepatic gene expression together with serum levels of LDL/VLDL-cholesterol, ox-LDL, total antioxidant status and various serum cardiovascular disease/proinflammatory markers were evaluated. Statistical analyses were performed using SPSS, and Shapiro-Wilk’s test was performed to determine the distribution of the variables. Statistical difference was assessed using One-Way ANOVA with Tukeys’ post hoc test or Kruskal-Wallis test. The hepatic relative gene expression was analysed with REST 2009 (V2.0.13). RESULTS: Mice fed CWO had less atherosclerotic lesions in the aortic arch compared to mice fed CO. Levels of LDL/VLDL-cholesterol and ox-LDL-cholesterol were also markedly reduced whereas total antioxidant levels were enhanced in mice fed CWO compared to CO-fed mice. In addition, CWO-fed mice gained less weight and several hepatic genes involved in the cholesterol metabolism were up-regulated compared to CO-fed mice. CONCLUSION: In the present study mice fed a WD supplemented with 1% CWO had reduced formation of atherosclerotic lesions in the aortic arch, reduced serum LDL/VLDL-cholesterol and ox-LDL-cholesterol, increased serum total antioxidant status and reduced body weight compared to mice fed a WD supplemented with 1% CO.
1000 Sacherschließung
lokal LDL-cholesterol
lokal Whale oil
lokal Blubber
lokal VLDL-cholesterol
lokal Atherosclerosis
lokal Balaenoptera acutorostrata
lokal Gene expression
lokal Lesions
lokal Plaque
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2FscXVpc3QsIE1hcmkgSm9oYW5uZXNzZW4=|https://frl.publisso.de/adhoc/uri/U3Rvcm1vLCBTdmVpbiBLcmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/w5hzdGVydWQsIEJqYXJuZQ==|https://frl.publisso.de/adhoc/uri/RWx2ZXZvbGwsIEVkZWwgTy4=|https://frl.publisso.de/adhoc/uri/RWlsZXJ0c2VuLCBLYXJsLUVyaWs=
1000 Label
1000 Förderer
  1. Universitetet i Tromsø |
  2. BlueOcean |
1000 Fördernummer
  1. UB0046
  2. UB0046
1000 Förderprogramm
  1. Marine Biotechnology in Tromsø
  2. Marine Biotechnology in Tromsø
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitetet i Tromsø |
    1000 Förderprogramm Marine Biotechnology in Tromsø
    1000 Fördernummer UB0046
  2. 1000 joinedFunding-child
    1000 Förderer BlueOcean |
    1000 Förderprogramm Marine Biotechnology in Tromsø
    1000 Fördernummer UB0046
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6417617.rdf
1000 Erstellt am 2019-11-20T11:58:38.434+0100
1000 Erstellt von 218
1000 beschreibt frl:6417617
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet Thu Jan 30 22:40:32 CET 2020
1000 Objekt bearb. Wed Nov 20 12:01:27 CET 2019
1000 Vgl. frl:6417617
1000 Oai Id
  1. oai:frl.publisso.de:frl:6417617 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source